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Abstract 
 
Evaluation of MRN Complex and ATM Protein-Protein Interactions 
using Cleavable DSSO Crosslinking and Mass Spectrometry 
 
Antony Martin Harvey, MA 
The University of Texas at Austin, 2017 
 
Supervisor:  Tanya T. Paull 
 
Ataxia telangiectasia (A–T) is an inherited autosomal recessive disorder caused 
by mutations in the ataxia telangiectasia mutated (ATM) gene. The canonical role of 
ATM is to induce cell checkpoint arrest following DNA damage. When cells experience 
DNA double-strand breaks (DSBs), the Mre11-Rad50-Nbs1 (MRN) complex senses the 
damage, activating ATM, which mobilizes a protective signaling cascade, activating the 
cell cycle checkpoint, arresting cell growth. If the extent of damage is excessive, the 
apoptotic pathway is activated; otherwise DNA repair is initiated using either 
homologous recombination (HR) or through non-homologous end joining (NHEJ). 
ATM also plays a key role in redox homeostasis. Loss of this cellular function 
results in the misfolding and aggregation of proteins. Misfolded proteins are degraded by 
three pathways: the ubiquitin proteasome system (UPS), macroautophagy and chaperone-
mediated autophagy (CMA). Aggregated proteins that are resistant to these protein 
clearance mechanisms can form inclusion bodies, which can lead to neurodegeneration. 
 vi 
The primary approach used for investigating protein interactions in this research 
was with the DSSO cleavable crosslinking technique: first to evaluate the MRN protein 
complex structure and protein-protein interactions; then to elucidate ATM binding 
partners in cells undergoing oxidative stress. 
The results of the MRN complex in vitro crosslinking experiment were that 53 
unique crosslinks were detected. These were subsequently evaluated by calculating 
molecular distances between identified crosslinked residues using known crystal 
structures of homologous proteins.  
Conversely, the results of the ATM in vivo crosslinking experiment were that, 
while informative crosslinks were not detected between ATM and other proteins, certain 
pathways were over-, and under-represented in the Co-IP of cells expressing the ATM 
constructs. Specifically, the parkin-ubiquitin proteasomal system pathway was over-
represented, while the proteasome degradation pathway was under-represented. 
Additionally, the small heat shock protein 27 (Hsp27) was found to be enriched, a 
chaperone known for its protective role in protein aggregation diseases. 
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INTRODUCTION 
Ataxia telangiectasia (A–T), or Louis-Bar syndrome, is an inherited autosomal 
recessive disease caused by mutations in the ataxia telangiectasia mutated (ATM) gene. 
The canonical role of ATM is to maintain genome fidelity by facilitating repair following 
double-strand DNA breaks. ATM also plays a key role in redox control during oxidative 
stress. Loss of these two cellular functions is believed to underlie the source of A–T 
patients’ physiological and neurological symptoms (1-3).  
Cells with mutated ATM can undergo damage due to oxidative stress (4-6). ATM 
has been observed to form a covalent disulfide dimer following oxidative stress, and to 
phosphorylate substrates that inhibit cell growth and to activate autophagy via the 
mTORC1 pathway (7-9). ATM’s inability to form a covalent dimer in response to 
oxidative damage may result in A–T patients losing sensory function in their neuronal 
cells (10). A specific separation-of-function, redox homeostasis-deficient ATM mutant 
has been found to result in the cell experiencing deficiencies in mitochondrial function 
and autophagy, leading to widespread protein aggregation (11). 
While arsenite stress to cells normally initiates the cellular redox control pathway 
(12, 13), when ATM is mutated, ROS damage goes unchecked (14). The cellular 
response to ROS is one of the primary areas of investigation in this thesis. 
When cells experience double-stranded DNA breaks due to exogenous sources 
(e.g. environmental factors such as ionizing radiation) or endogenous sources (e.g. free 
radicals formed through normal oxidative metabolism), a protective signaling cascade is 
mobilized (15). The Mre11-Rad50-Nbs1 (MRN) complex senses the damaged DNA, 
activating ATM, which phosphorylates DNA damage mediators (e.g. 53BP1, MDC1, 
BRCA1, H2AX) as well as downstream kinases (CHK2, p53), activating the cell cycle 
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checkpoint and arresting cell growth (14-20). If the extent of DNA damage is excessive, 
the apoptotic pathway is activated; otherwise DNA repair is initiated using either 
homologous recombination (HR) during the S and G2 cell cycle phases, or through non-
homologous end joining (NHEJ) (21).  
The primary approach used for investigating protein interactions in this research 
was the DSSO cleavable crosslinking technique (22). Crosslinking proteins in vivo and in 
vitro enables one to infer which proteins were interacting at the time of the crosslinking 
reaction. Since DSSO cleavable crosslinking is still a relatively new protocol, the 
technique was first optimized using a purified MRN protein complex sample. 
Optimization of the crosslinking protocol and the evaluation of the MRN protein complex 
structure are the two other primary areas of investigation in this thesis. 
Ataxia Telangiectasia Mutated and Oxidative Stress 
Patients with ataxia telangiectasia (A–T) lack the normal ATM control of 
oxidative stress due to reactive oxygen species, resulting in the degeneration of cerebellar 
Purkinje cells (23-25). Neuronal cells are especially prone to oxidative stress-induced 
damage, in large part due to the the higher level of mitochondrial activity (26-29). 
Consequently, A–T patients undergo progressive neurodegeneration and suffer the effects 
of reduced cognitive function, and loss of coordination and fine motor control (30). As 
there currently is no established therapy for A–T (31), a better understanding of ATM 
dysfunction experienced by A–T patients may shed new insight into possible 
interventions for treating the effects of cellular damage due to oxidative stress. 
Certain redox pathways are initiated due to oxidative stress, such as the 
Nrf2/Keap1 pathway (32), which serves both to initiate the expression of antioxidant 
genes (33) as well as to activate autophagy by up-regulating p62 (34). p53 is central to 
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another ROS-sensing pathway that promotes autophagy through the regulation of DRAM 
(35). ROS also result in the misfolding of proteins (36), which must be dealt with by the 
cellular 'protein quality control' system (37). 
Misfolded proteins are primarily degraded by three pathways in mammalian cells: 
the ubiquitin proteasome system (UPS), macroautophagy and chaperone-mediated 
autophagy (CMA) (38-40). In the UPS pathway, slow-folding or misfolding proteins are 
recognized by ubiquitin ligases, which mark them for proteasome degradation (41). In 
macroautophagy, proteins are first assembled into aggresomes that are subsequently 
degraded by lysosomes (42). In CMA, misfolded proteins that display the consensus 
sequence KFERQ are recognized by chaperones and delivered directly to lysosomes for 
degradation. Aggregated proteins that are resistant to these three mechanisms can form 
inclusion bodies, or plaques, and can lead to neurodegenerative disease phenotypes (40). 
The mechanism of protein aggregation and dysfunction in protein clearance in 
A–T is currently not well characterized, but it may resemble other protein aggregation 
and neurodegenerative diseases. While a mouse model of A–T did not result in a 
significant loss of atm -/- Purkinje cells, the neuronal cells reentered the cell cycle event 
(CCE), a process which can lead to neuronal cell death (43, 44).  The ATM protein is also 
activated as a result of protein aggregation in Huntington’s disease (HD), and the clinical 
phenotype of HD resembles A–T, including ataxia and cerebellar atrophy (45-48). 
Research into these neurodegenerative diseases has characterized the cellular 
processes in which aggregated proteins are recognized and directed into the autophagy 
pathway. In Parkinson's disease (PD), parkin mediates lysine-63 (K63) linked 
polyubiquitination of misfolded proteins, triggering the retrograde transport of aggregated 
proteins to the nucleus to form Lewy bodies (27, 49). The proteins are then collected into 
an aggresome, followed by the assembly of an autophagic membrane, fusion to a 
 4 
lysosome and degradation via autophagy. However, the role of ubiquitination is not fully 
understood in this process. In amyotrophic lateral sclerosis (ALS) disease, the Bcl-2-
associated athanogene 3 (BAG3) – Hsp70 complex couples mutant superoxide dismutase 
(SOD) to the retrograde dynein motor to form Bunina bodies independent of an 
ubiquitination event (50-53). 
Making use of the discovery that a disulfide-crosslinked ATM dimer is formed in 
response to oxidative stress (9), Paull, et al., created a separation-of-function ATM 
mutant (C2991L) that does not form this covalent dimer. Using it, they found that the cell 
cycle checkpoint was not activated following ROS treatment.  
It was also confirmed that the adverse effects of the C2991L mutant on cell 
homeostasis extended to the mitochondria, in which membrane potential was lower, and 
levels of carnitine (and its derivatives) was higher due to deficiencies in mitochondrial 
function. Cellular compartment turnover was also affected, in that mitochondria were not 
effectively delivered to lysosomes for recycling via mitophagy, and other organelles were 
not properly recycled through autophagy. The investigations also found widespread 
protein aggregation in the C2991L mutants, especially upon arsenite treatment (11). 
Research performed in our lab also revealed that heat shock proteins co-purify 
with ATM (2), so interactions between ATM and HSPs are of particular interest. The 
small heat shock protein 27 (Hsp27, also referred to as HSPB1) has been found to be 
highly expressed in the frontal cortex of A–T patient brains—conversely, the expression 
of other heat shock proteins, including Hsp70, is unchanged as compared to controls (54). 
Hsp27 is known for its protective role in the protein aggregation diseases HD, AD and 
ALS (55). Hsp27 is also known to function as a molecular chaperone of intermediate 
filaments (56). This suggests that Hsp27 might function similarly to HSPB8, which 
associates with the aggresome intermediate filaments vimentin, nestin and glial fibrillary 
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acidic protein (51). However, as other data indicates that BAG3 directs Hsp70 substrates 
to aggresomes (57), the specific mechanism of aggresome formation in ATM mutants is 
not clear—it could involve one, both or neither of these two heat shock proteins. 
Moreover, it’s also not clear whether macroautophagy or CMA is the primary clearance 
pathway for misfolded and aggregated protein being used by ATM mutant cells. 
Studies have also documented ATM mediated phosphorylation of heat shock 
proteins. ATM promotes Hsp27 phosphorylation in response to oxidative stress (58). In 
response to DNA damage, inducible heat shock proteins HSC70 (HSPA8), HSP72 
(HSPA1A), Hsp90 and Hsp90α are phosphorylated to stimulate DNA repair (59-62).  
ATM also mediates phosphorylation of HSPB1 via TAO and the MAP kinase cascade 
(3). 
During previous investigations with mouse models harboring kinase-dead ATM 
mutants, researchers noted that, while ATM null mice were viable, AtmKD/KD progeny 
were never produced, indicative of an embryonic lethal phenotype. Furthermore, they 
found that heterozygous kinase-dead/null ATM cells (AtmKD/-) had greater genomic 
instability than ATM null cells (Atm-/-) (63). This apparent oncogenic gain-of-function 
phenotype from a mutant tumor suppressor is not unlike that found with carcinogenic 
point-mutations found in p53 in atypical Li-Fraumeni Syndrome (LFS) (64). As ATM 
has critical roles in maintaining genomic stability (and is integrated with the p53 
checkpoint pathway), these similarities might not be unexpected. 
However, a detailed mechanism of the adverse ATM-kd cellular phenotype is not 
understood. A clue might be found in reviewing LFS-variant case studies in which the 
offending gene (or lack thereof) was not p53, but, rather, CHK2. In these cases, germline 
loss CHK2, or loss of (mutant-CHK2) heterozygosity resulted in the LFS phenotype (65). 
Since a loss of CHK2 results in unchecked Mdm2-mediated clearance of p53, genetic 
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instability and DNA damage accumulate, resulting in a multicancer phenotype (65, 66). 
In the same fashion, a kinase-dead ATM could both fail to initiate checkpoint arrest of 
cell growth due to a lack of kinase activity or because of irreversibly binding to a DDR 
tumor suppressor. 
Latent accumulation of genetic damage can also account for the fact that mouse 
models and cell lines with homozygous null tumor suppressor genotypes (both ATM and 
p53) are initially viable, but inevitably result in a carcinogenic phenotype (63-68) or 
degraded cell viability (11). 
Nevertheless, while the germline kinase deficient ATM mutants result in 
embryonic lethality in mice, temporally-expressed kd-ATM can still be a useful tool in 
studying ATM function in the cell. As was previously described, the kinase-deficient 
ATM mutant (kd-ATM) was found deficient in checkpoint activation following both CPT 
(camptothecin, DNA-damage inducing) as well as sodium arsenite treatment (11).  
In the research described herein, to elucidate the substrate and binding partners of 
ATM in cells undergoing oxidative stress, both wild type and kinase-deficient ATM 
constructs were expressed in 293T cells and enabled co-IP enrichment using the FLAG 
tags. The kinase-deficient mutant ATM (kd-ATM) used in the investigations had two 
amino acid substitutions (D2886A and N2891K1) abolishing its ability to phosphorylate 
substrate2 (11), but potentially also extending ATMs interaction time with its substrate, 
enhancing DSSO crosslinking. 
                                                 
1
 The residue numbers for the kinase-deficient sequences account for the two N-terminal tags. 
2
 This mutant is unable to phosphorylate substrate in response either to DNA damage or oxidative stress. 
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The MRN Complex 
The human MRN complex and homologous yeast Mre11-Rad50-Xrs2 (MRX) 
complex are critical to DNA double-strand break (DSB) repair in both mitosis and 
meiosis. The Mre11-Rad50-Xrs2/Nbs1 (MRX/N) complex has been shown to be 
involved in sister chromatid repair, homologous recombination (HR), non-homologous 
end joining (NHEJ), meiotic recombination, and telomere maintenance, participating in 
DNA repair during all phases of the cell cycle and during nuclear division of somatic 
cells as well as during meiosis (69-76). 
Nbs1 gets its name from Nijmegen breakage syndrome (NBS), highlighting its 
role in maintaining genome stability. When there is a germ line mutation of Nbs1, cells 
undergo chromosomal breakage during replication and patients exhibit symptoms similar 
to A–T (77, 78). With certain Mre11 mutations, the DSB repair pathway is abrogated, 
resulting in an ataxia telangiectasia-like disorder (ATLD) (79). Both types of pathological 
mutations affect MRN complex interactions with ATM. Deficiencies in Rad50 can result 
in chromosomal instability, radiation hypersensitivity, predisposition to cancer and a 
phenotype similar to NBS in a disorder classified as Nijmegen breakage syndrome-like 
disorder (NBSLD) (80, 81). 
Mre11 acts as a scaffold, in which a single His-to-Tyr amino acid substitution3 
abolishes formation of the MRX complex (70, 82). The N-terminal region of yeast Mre11 
has also been shown to be necessary for homo- and hetero-dimerization, and the acidic 
heptad repeat near the C-terminus is important for full self-association (70, 71, 83). 
Evolutionarily-conserved Mre11 interacting regions (MIRs) also exist within both Rad50 
and Nbs1 (81, 84-88). Within the human Nbs1 MIR is the NFKxFxK motif which, 
                                                 
3
 The substituted amino acid residue His213 in Saccharomyces cerevisiae is conserved residue His217 in 
Homo sapiens protein Mre11. 
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elucidated in a S. pombe crystal structure, revealed a surprising, asymmetrical association 
across the Mre11 dimer interface (81). 
Through multiple sites of interaction, MRN recruits ATM following double-
strand DNA breaks (16, 17, 89). Within the MRN complex, there are evolutionary-
conserved regions required for ATM recruitment to damaged DNA. The C-terminus of 
Nbs1 contains an ATM-interaction motif (84, 87); and Rad50 in the Mre11/Rad50 (MR) 
complex recruits monomeric ATM to sites of DNA damage (16, 17).  
Analysis of Protein Interactions using Crosslinking-Mass Spectrometry 
In the DSSO cleavable crosslinking-mass spectrometry experiment, tandem 
spectra from crosslinked peptides are analyzed by the XlinkX algorithm developed by the 
Albert Heck Laboratory to elucidate protein binding partners in vivo (90, 91). In brief: 
proteins are crosslinked to their normal binding partners under experimental conditions, 
protein complexes of interest are enriched and analyzed using mass spectrometry.  
To characterize the interactions ATM makes in cells undergoing oxidative stress, 
FLAG-tagged constructs of ATM were used to permit IP enrichment4 (92). Cells were 
then incubated with oxidizing agents and, while cells were still responding to the stress, 
the proteins were crosslinked. The cells were then harvested, lysed and purified by 
immunoprecipitation. The purified protein complexes were then prepared for mass 
spectrometry analysis; they were reduced, alkylated and digested. The crosslinked 
peptides were then analyzed: peptides were chromatographically separated using a C18 
reversed-phase column and analyzed using an Orbitrap Fusion hybrid mass spectrometer, 
                                                 
4
 The wild type (pATMwt-Flag) and kinase deficient plasmids (pATMkd-Flag) were gifts from Michael 
Kastan.  
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which contained the necessary firmware to perform the MSn crosslinking instrument 
acquisition.  
Mass spectrometry analysis of cleavable crosslinked peptides employed the MSn 
method: (crosslinked) peptides eluting from the HPLC system, detected in the precursor 
(MS1) scan, were isolated and fragmented with a low-energy collision-induced 
dissociation (CID) waveform (22).  The low energy fragmentation generates two sets of 
characteristic peptide masses offset by the mass of the sulfoxide moiety from the 
cleavable DSSO linker (22)5. The instrument then sequentially isolates each of the 
peptides and fragments them with higher-energy collision dissociation (HCD), scanning 
out the individual peptide fragments in subsequent MS3 scan events.  
Acquired tandem spectra were then analyzed using the XlinkX algorithm included 
in the Proteome Discoverer 2.2 release of software. From the Orbitrap Fusion method 
editor, the 'Cleavable MS2-MS3' Peptides-Xlink MS acquisition template was used as a 
starting point, and incremental changes were made during method development to 
optimize detection of crosslinked peptides. The detection of crosslinked, highly-confident 
peptides infers that the two parent proteins were closely associated at the time of 
crosslinking. For the ATM analysis, ATM binding partners were co-precipitated with the 
FLAG-tagged ATM protein during IP purification step prior to sample preparation for 
mass spectrometry analysis. 
                                                 
5
 Gas-phase rearrangement during DSSO linker fragmentation results in dehydration such that the delta 
mass observed in the mass spectrometer is 31.97208 Da instead of the expected mass of sulfoxide. 
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MATERIALS AND METHODS 
The materials and methods used in this research are described, below: 
Tissue Culture 
HEK 293T/17 cells (ATCC, CRL-11268) were grown (at 37 °C, 5% CO2, in 
humid incubator) in Dulbecco's Modified Eagle Medium (Fisher Scientific, 11995-073) 
supplemented with 10% fetal bovine serum (Gemini Bio-Products, 100-135)6 and 1% Pen 
Strep (Fisher Scientific, 15140-122). 
Protein Expression and Purification 
MRN COMPLEX PROTEIN SEQUENCES 
Mre11 contains a linker sequence (LGA) followed by the FLAG tag 
(DYKDDDDK) at the C-terminus. Rad50 contains a linker sequence (PPAAAGG) at the 
location of the deleted coiled-coil domain, and the HA sequence (YPYDVPDYA) 
followed by a His-tag (HHHHHH) at the C-terminus. The coiled-coil domain deletion 
mutant of Rad50 was created using PCR amplification of the N-terminus (a.a. 1-216), the 
linker sequence, and the C-terminus (a.a. 1104-1312) of Rad50, as previously described 
(93). Nbs1 was the canonical sequence. The human MRN complex (hMRcdN) protein 
sequences are listed in the Appendix. 
MRN COMPLEX EXPRESSION AND PURIFICATION 
The human MRN complex proteins were expressed in Sf21 insect cells 
(Invitrogen, B82101) by co-expression using the Bac-to-Bac7 baculovirus expression 
                                                 
6
 Chrysalis Insect Cell Qualified FBS was utilized for the purpose of depleting otherwise expiring stock. 
7
 Mutant transfer vector pTP516 (Rad50cd), and wild type transfer vectors pTP813 (wt-Mre11) and 
pTP288 (wt-Nbs1) were converted into bacmids pTP542 (Rad50cd), pTP814 (wt-Mre11) and pTP291 (wt-
Nbs1), which were then used to make the viruses according to the manufacturer’s instructions. 
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vector system (Life Technologies) as previously described (85, 93-95). The Spodoptera 
frugiperda insect cells expressing the hMRcdN complex were lysed in Ni-NTA buffer 
(50 mM KH2PO4, 10% glycerol, 2.5 mM imidazole, 20 mM β-mercaptoethanol, 0.5 M 
KCl), homogenized and sonicated. The lysates were cleared using ultracentrifugation and 
loaded onto Ni-NTA agarose resin (QIAGEN). The proteins were washed, then eluted 
with Ni-B buffer (50 mM KH2PO4, 10% glycerol, 250 mM imidazole, 20 mM 
β-mercaptoethanol, 50 mM KCl). The eluate was then loaded onto 1 mL of anti-FLAG 
M2 affinity resin (Sigma, A2220-2), washed with Buffer A (25 mM Tris pH 8.0, 100 mM 
NaCl, 10% glycerol, 1 mM DTT) and eluted with 0.1 mg/mL of FLAG peptide (Sigma) 
in Buffer A. The peak fractions were loaded onto and eluted from a Superose 6 column 
(GE Healthcare) equilibrated with a modified MOPS buffer (25 mM MOPS pH 7.0, 100 
mM NaCl, 2% glycerol, 1 mM DTT), which enabled crosslinking later without 
quenching of the DSSO crosslinker reagent. The aliquots from the peak fractions were 
flash frozen and stored at -80°C until use (85). 
ATM CONSTRUCT PROTEIN SEQUENCES 
The wild type (pATMwt-Flag) and kinase deficient plasmids (pATMkd-Flag) 
were gifts from Michael Kastan (92). Both the wild type and kinase-deficient ATM 
sequences include a FLAG tag (DYKDDDDK) followed by a His-tag (HHHHHH) at the 
N-terminus. The kinase deficient sequence contains two additional mutations, D2886A 
and N2891K8. Since the detection of the FLAG peptide was skewing the ATM quan 
results, the N-terminal FLAG sequence was omitted from the FASTA file for Proteome 
Discoverer searching of proteins binding to the ATM constructs. Additionally, since the 
sequenced plasmid contained two additional amino acid substitutions that were 
                                                 
8
 The residue numbers for the kinase-deficient sequences account for the two N-terminal tags. 
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contradicted by the mass spec analysis, those were also omitted and the canonical 
sequences were instead used for data analysis. 
ATM CONSTRUCT EXPRESSION 
Calcium phosphate transfection was used to induce ATM expression in the 293T 
cells, as previously described (89, 92). 
ROS Treatment of Cells 
HEK 293T/17 (293T) cells were grown to 80% confluency on 15-cm plates in 
20 mL of media, to which was added 10 µL of 50 mM AsO3 solution for a final As(III) 
concentration of 25 µM, and incubated over-night for 18 hours. Cells were then 
harvested. 
Cell Harvesting 
Forty-eight 150-mm plates of each experimental condition of 293T cells were 
harvested in the biohazard hood using ice-cold PBS (with 25 µM AsO3 to continue the 
ROS treatment until just before crosslinking) using physical agitation and a gentle stream 
of solution to dislodge the cells. Cells were collected into 15 mL Falcon tubes (four plates 
per tube), which were kept on ice until crosslinking. Falcon tubes were centrifuged at 
4 °C, 100×g to concentrate cells during triple PBS rinses. 
Protein Crosslinking 
Proteins were crosslinked using the DSSO (disuccinimidyl sulfoxide) reagent 
(Thermo Scientific, A33545)9 according to the vendor’s recommendations. The MRN 
                                                 
9
 Publication number MAN0016303 Revision A.0. 
 13 
complex proteins were crosslinked using the in vitro protocol, and the ATM proteins 
were crosslinked using the in vivo protocol. Details of the crosslinking protocols follow: 
IN VITRO MRN COMPLEX CROSSLINKING 
Purified 20-µL aliquots of ~300 nM MRN complex protein samples in 25 mM 
MOPS, 100 mM NaCl and 2% glycerol were removed from 80 °C freezer and thawed on 
ice. DSSO reagent was removed from 4 °C refrigerator and warmed to room temperature. 
DSSO reagent was reconstituted by adding 51.5 µL of DMSO to make 50 mM stock 
solution. 42 µL of DSSO stock solution was added to the MRN complex aliquot (42 µL 
of DMSO was added to the control), for target 300:1 linker to protein ratio, and was 
gently vortexed to mix. The sample – reagent solution was permitted to incubate for 60 
minutes at room temperature, then the reaction was quenched by adding 1.25 µL of 1 M 
Tris buffer, pH 8.0. Crosslinked proteins were then reduced, alkylated and digested using 
the FASP protocol. 
IN VIVO ATM CELL CROSSLINKING 
Fifty-mL Falcon tubes of harvested cells, on ice, were rinsed with ice-cold PBS to 
remove AsO3 solution. DSSO reagent was removed from 4 °C refrigerator and warmed to 
room temperature. Each 1 mg vial of DSSO reagent was reconstituted by adding 51.5 µL 
of DMSO to make 50 mM stock solution. 463.5 µL of ice cold PBS was added to each 
51.5 µL stock of 50 mM DSSO to make the final 5 mM DSSO crosslinking solution. 
Using the Tecan Spark Multimode Microplate Reader, cell count was estimated to be 
approximately 2.8 × 109 per treatment sample—far exceeding the target of 107 cells—so 
four vials of DSSO reagent were used to crosslink each sample of harvested cells. Excess 
PBS was removed from the cells, then 2.06 mL of 5 mM DSSO crosslinking solution was 
added to each cell sample and vortexed to mix (the same amount of DMSO was added to 
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the control). The sample–reagent solution was permitted to incubate in ice for 30 
minutes. The reaction was then quenched by adding 20 µL of 1 M Tris buffer, pH 8.0, 
and permitted to incubate on ice for 15 minutes. Excess Tris–PBS solution was removed 
from the cells, the cells were then flash frozen and stored at -80 °C until they were ready 
for FLAG-tag immunoprecipitation.  
Sample Preparation 
The samples were prepared for mass spectrometry analysis, from both the in vitro 
crosslinked MRN complex and in vivo crosslinked ATM proteins, using the following 
protocols: 
FLAG-TAG IMMUNOPRECIPITATION (CO-IP) 
FLAG-tag immunoprecipitation was used to extract ATM and its crosslinked 
clients, as previously described (89, 96). FLAG-tag enriched proteins were then reduced, 
alkylated and digested using the FASP protocol. 
FILTER-AIDED SAMPLE PREPARATION (FASP) 
Crosslinked samples were prepared for mass spectrometry analysis using a 
modified version of the Filter-Aided Sample Preparation (FASP) method described by 
Wisniewski et al. (97), taking special care to prevent filter leakage during filtering steps 
(98). In brief, Microcon-30kDa centrifugal filters (EMD Millipore, MRCF0R030) are 
first prewashed by adding 400 µL of a rinse solution (20% ACN, 2% formic acid) and 
centrifugal spinning at 10,000 × g10. The samples are then diluted 5:1 with UA solution 
(8M urea in Tris buffer, pH 8.8), added to the filters and centrifuged. The samples are 
then rinsed twice with 400 µL of UA solution and the proteins are reduced by incubating 
                                                 
10
 Reduced centrifuge speeds were used to prevent filter breakage during filtering steps  
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with 400 µL of 50 mM dithiothreitol in UA (Fisher Scientific, BP172-5) for five minutes. 
The filter cartridges are again centrifuged and the proteins are alkylated with 400 µL of 
50 mM iodoacetamide (Sigma-Aldrich, I1149-5G) for five minutes. The filter cartridges 
are centrifuged, and then rinsed twice with 400 µL of 40 mM ammonium bicarbonate, 
pH 7.8 (Fisher Scientific, A643-500)11. 
PROTEIN DIGESTION 
The reduced and alkylated proteins were digested on filter using several different 
enzymes to produce peptides of different lengths and amino acid composition in order to 
increase protein coverage during subsequent analysis. In each case, 0.5 µg of enzyme was 
dissolved in 100 µL of 40 mM ammonium bicarbonate buffer, the solution was added 
directly to the centrifugal filters, the filter devices were closed and vortexed to mix, and 
then placed in a sample box with moistened towels and incubated overnight at 37 °C. 
The following mass spectrometry grade enzymes were used to digest the protein 
samples: GluC V-8 endoproteinase (New England Biolabs, P8100S), Trypsin Gold 
(Promega, V5280), chymotrypsin (Roche, 11418467001), and LysN protease (Pierce, 
90300). 
PEPTIDE DESALTING 
Following protein digest, samples were eluted with 20% ACN, 2% formic acid, 
evaporated to dryness (Eppendorf Vacufuge 5301 Concentrator), resuspended with with 
0.5% LC-MS grade TFA (Thermo Scientific, 85183), then desalted using the DigestPro 
MSi robotic sample preparation instrument (INTAVIS Bioanalytical Instruments). 
                                                 
11
 For samples to later be digested with GluC endoproteinase, the final FASP rinses were instead 
performed with NEB GluC reaction buffer. 
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XL-MS Data Acquisition and Analysis 
Data was acquired with the Orbitrap Fusion Tribrid mass spectrometer, using scan 
parameters defined in the standard Peptides-Xlink cleavable MS2–MS3 template, with 
the following modifications: MS2 charge state filter included charges 2–15 as well as 
undetermined charge states, MS2 intensity threshold was 5.0×e3 and The MS3 charge 
state filter was removed.12  
Data was analyzed using the DSSO_MS2_MS3.pdAnalysis default Proteome 
Discover 2.2 template, with the following notable changes: Semi-enzymatic specificity 
was used instead of the default ‘full’ setting (specific enzyme selected based upon digest 
performed for actual sample). A minimum peptide length setting of 3 was used instead 
of 5 for the XlinkX search node. Additional dynamic modifications included deamidation 
(of asparagine), dehydration (of serine and threonine), a delta mass of +12.000 Da (on the 
peptide N-terminus13) and methionine loss/acetylation (at the protein N-terminus).  
To perform an independent evaluation of crosslinked spectra, a Scan Event Filter 
node was connected to the Spectrum Selector to pass MS3 spectra (only) directly to 
another Sequest HT14 node, using the same search parameters as the XlinkX search node, 
plus additional dynamic DSSO alkene and thiol fragment modifications15. 
Protein Homology, Pathway and Structural Analysis 
Once crosslinks were determined from the acquired data, the interacting regions 
were evaluated further using the following software tools: 
                                                 
12
 Even with this reduced intensity threshold value, some crosslinked peptide intensities fell beneath this 
value, not triggering an MS3 acquisition, ultimately resulting in a lowered crosslink spectrum match score. 
13
 Artefacts suggested by Preview™ by Protein Metrics, Inc. © 2011-2017. 
14
 SEQUEST® is used by Proteome Discoverer under license from the University of Washington. 
15
 DSSO alkene fragment formula: C(3)OH(2); DSSO thiol fragment formula: C(3)OSH(2). 
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PROTEIN CROSSLINK VISUALIZATION 
Following computational analysis of the mass spectrometry data of crosslinked 
proteins, a fasta file of the proteins and a CSV file of the crosslinks were exported from 
Proteome Discoverer. An additional CSV file was manually created to annotate the 
protein domains, and all three files were uploaded to the xiNET cross-link viewer at 
http://crosslinkviewer.org/ (99). Wild type proteins, which contain canonical sequences 
and are described in the fasta file using the standard UniProtKB accession, can be 
automatically annotated in the online viewer with the UniProt and SuperFamily domains 
(100-102). 
PATHWAY OVER-REPRESENTATION ANALYSIS 
Pathway over-representation analysis was performed by uploading the accessions 
of enriched proteins to the Thermo Scientific pathway over-representation cloud 
application at https://apps.thermofisher.com/apps/lsms/pa/#/. The June 2016, Revision B 
of the web application uses pathway information from the WikiPathways, KEGG (Kyoto 
Encyclopedia of Genes and Genomes) and Reactome Pathway database repositories.16 
SEQUENCE HOMOLOGY SEARCHES 
Protein BLAST searches were performed on the NCBI BLASTp website 
https://blast.ncbi.nlm.nih.gov/Blast.cgi?PROGRAM=blastp&PAGE_TYPE=BlastSearch
&LINK_LOC=blasthome (103). 
Sequence homology searches were also performed with available structures on the 
Research Collaboratory for Structural Bioinformatics (RCSB) Protein Data Bank (PDB) 
to at https://www.rcsb.org/pdb/home/home.do#Subcategory-search_sequences (104). 
                                                 
16
 WikiPathways content is provided under the Creative Commons CC BY-NC-SA 3.0 License. KEGG is a 
Copyright © of Pathway Solutions Inc. and Kanehisa Laboratories. Reactome is a Copyright © of Cold 
Spring Harbor Laboratory and the content is provided under the Creative Commons Attribution 4.0 
International License. 
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Evaluation of evolutionarily conserved sequences was performed using the T-
Coffee algorithm at http://tcoffee.vital-it.ch/apps/tcoffee/do:regular (105, 106). 
STRUCTURAL VISUALIZATION AND MEASUREMENTS 
Protein complex visualization and molecular measurements were performed with 
the PyMOL Molecular Graphics System, Version 2.0.1 Schrödinger, LLC (107). 
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RESULTS AND DISCUSSION 
A discussion of the results of this research are described, below: 
DSSO Crosslinking 
DSSO crosslinking was performed on purified MRN complex proteins, with and 
without additional nucleotides (ATP), proteins (ATM) and cofactors (MgCl2). 
Crosslinking was also performed on sets of 48 15-cm plates of 293T cells expressing the 
different ATM constructs (wild type, and kinase-dead), which were treated for 18 hours 
with 25 µM AsO3. The following sections describe the modifications made to the 
standard protocols suggested by the mass spectrometry equipment and reagent 
manufacturer: 
OPTIMIZING CHEMICAL CROSSLINKING PROTOCOL 
The DSSO reagent was titrated into the purified MRN complex sample targeting 
the manufacturer's recommended range of 20–400 fold molar excess of crosslinker-to-
protein complex concentration (see Illustration 1, below). In agreement with the 
manufacturer’s protocol, while crosslink reporter peaks were found with DSSO 
concentrations below the 20× molar excess, no crosslinks could be confidently identified 
by the XlinkX algorithm. When crosslinking the ATM construct-expressing cells, a 
recommended final crosslinker concentration of 5 mM of DSSO was used; although 
significantly more cells were treated at once than the 107 cells specified in the protocol. 
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Illustration 1 Number of crosslinks found with DSSO concentration 
In the following sections, the significance and relevancy of the detected crosslinks 
is discussed, but, in general, the following principles were taken in consideration: Both 
inter- and intra-protein crosslinks were compared with the currently-known protein 
structures to determine whether they were in agreement with known dimensions and 
atomic distances. The crosslinks were also evaluated based upon whether they were 
detected reproducibly, and if its XlinkX score was above the 1% FDR threshold using the 
Percolator validation method (90, 108)17. The reagent and protein concentrations for each 
experiment were controlled to keep as much as possible within the manufacturer’s 
recommendations to reduce non-specific protein-protein interactions. 
                                                 
17
 In the event that there are not enough crosslink spectrum match candidates, the Percolator validation 
approach may fail, in which event the Xlinkx validator reverts to target-decoy FDR validation. 
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ALTERNATIVE ENZYME DIGESTION APPROACHES 
Digestion with trypsin yielded the most number of identifiable crosslinks from the 
DSSO crosslinking experiments. Of the 53 crosslinks detected in the experiments, 41 
were found using trypsin as the digesting enzyme. Even more revealing, of the 115 
detected peptides linked by DSSO, 81 contained an arginine residue at the C-terminus, 
while only three had lysine at the C-terminus—indicating that the DSSO crosslinker 
inhibited trypsin hydrolysis of peptide bonds adjacent to lysine.  
A small percentage (5%) of the crosslinked peptides were cleaved at the 
N-terminus of a crosslinked lysine residue, which suggested that the LysN enzyme 
(Peptidyl-Lys metalloendopeptidase) might give complementary results to trypsin. 
However, due to the higher-frequency of missed cleavages (up to 5 missed cleavages per 
individual peptide), the peptides were much larger (up to 29 a.a. residues per crosslinked 
peptide), had multiple crosslinks and/or linker fragments and were uninterpretable by the 
XlinkX algorithm—in fact, no crosslinks were successfully identified, despite an 
otherwise high percentage of crosslink reporter peaks detected in the MS2 spectra. 
The rest of the crosslinks detected in the experiment were from either the 
chymotrypsin or GluC digestion, resulting in ten and two additional crosslinks, 
respectively. Even more discouragingly, only one of the crosslinks was an inter-crosslink 
between different proteins within the complex, and it received the lowest XlinkX score 
(7.60) of all the crosslinks detected. The major drawback of these alternative enzymes 
was the much lower likelihood that the peptides contained basic residues in their amino 
acid sequence, and were thus not carrying a positive charge so that they could be detected 
in the mass spectrometer. 
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OPTIMIZING XL-MS DATA ACQUISITION 
A couple important changes were made to the default crosslinking acquisition 
template to enable additional crosslinked peptides to be detected by the mass 
spectrometer and subsequently processed by the software algorithms. Specifically, the 
precursor ions included for MS2 fragmentation and further mass spectrometric analysis 
was modified from the default of 4–8 charge state to include ions with charge states as 
low as +2.  
 
Illustration 2 Default Orbitrap Fusion peptides-Xlink acquisition template 
with removed MS3 charge state filter node highlighted blue. 
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These changes permitted the analysis of peptides cleaved by alternative enzymes 
that did not cleave at basic residues (which, consequently, have lower charge states due to 
the peptides having a lower frequency of lysine and arginine residues).  
Additionally, the charge state filter for MS3 fragmentation was removed to permit 
the inclusion of singly-charged peptides, as was the case for most of the GluC-digested 
MRN crosslinks and half of the chymotrypsin-digested crosslinked peptides (Illustration 
2 , above).  
OPTIMIZING DATA PROCESSING 
To account for incomplete enzymatic digestion, a ‘semi’ enzymatic specificity 
was used in the search algorithm. To ensure that smaller peptides were detected by the 
XlinkX search node, the minimum peptide length was reduced from 5 to 3. Smaller 
peptides were generated during GluC and Chymotrypsin digestions, but the shorter 
peptide lengths still did not produce ambiguous crosslinks18, as defined by the xiNET 
cross-link viewer (99). Common post-translational modifications were added to the 
default search parameters, such as dehydration of serine and threonine and loss of 
methionine/acetylation of the protein N-terminus. To account for chemical artefacts 
produced during sample preparation, additional dynamic modifications (deamidation of 
asparagine and +12 delta mass of peptide N-terminus19) were also included. Finally, the 
hydrolyzed DSSO modification of lysine was also added to the XlinkX search node to 
include peptides that contained dead-end crosslinking modifications. 
                                                 
18
 Ambiguous crosslink data results from (especially short) amino acid sequences that are found more than 
once within a single protein or in more than one protein. 
19
 Artefacts suggested by Preview™ by Protein Metrics, Inc. © 2011-2017. 
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Without these additional dynamic modifications, several redundant crosslink 
spectrum matches would be missed, but only one unique, low scoring crosslink20 would 
not have been identified, so the increased complexity of the search parameters is not 
entirely necessary to analyze the mass spectrometry data. 
Evaluating Crosslinking Results 
Fifty-three unique crosslinks were found within and between the MRN complex 
proteins, and each crosslink was identified an average of two times (see Figure 1, below).  
Most crosslinks were identified in at least two replications for the particular 
enzyme preparation (unique crosslinks were typically only identified in a single type of 
digest, due to the different cleavage specificities of the enzymes). The most reproducible 
crosslinks were also found in multiple charge states (e.g. +3 and +4) in each replicate. 
times and from the different replicates. The most reproducible crosslinks were also 
assigned much higher XlinkX crosslink scores. For example, the intra-crosslink between 
residues 510 and 609 of Mre11 was found in multiple charge states in the five trypsin 
digests, and in ten separate sets of mass spec scans (the crosslink peptide pairs were 
detected in 10 separate MS2 spectra, and the individual peptides were confirmed by an 
additional 36 MS3 scans). The range of XlinkX scores for this unique crosslink was 
between 55.57 and 345.85. 
                                                 
20
 Crosslink assigned a low score due one of the crosslinked peptide pairs not being confirmed with tandem 
MS3 spectrum due to ion current beneath the specified intensity threshold in the acquisition method. 
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Figure 1 Fifty-three unique crosslinks detected in the MRN complex 
with the coiled-coil domain of Rad50 deleted (99)21. 
 
At the other end of the continuum were crosslinks that were found only once, 
from a single sample replicate, and/or with a low XlinkX score. As an example, the 
crosslink identified between residue 320 on Nbs1 and 442 on Mre11 was found only 
once, being assigned the lowest XlinkX score from the data set (7.60) and with only one 
of the peptides being 'confirmed' with a unique MS3 spectrum (and with an improbable 
number of modifications—four). For the purpose of evaluating the likelihood of this later 
                                                 
21
 The interactive image can be viewed at: 
http://crosslinkviewer.org/uploaded.php?uid=45fc37ae346f0222d6c89fd06c0afcd8335b2985  
Domains
ATM interacting region FHA domain Mre11 interacting region
BRCT I domain FLAG tag Nuclease and capping domain
BRCT II domain HA tag P-loop NTP hydrolases
DelCC linker His6 tag Rad50 interacting domain
D-loop H-loop SPxK motif
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crosslink, the candidate can safely be eliminated. The rest of the identified crosslinks fell 
somewhere between these two extremes, and require a somewhat more critical 
assessment. 
 
 
 
 
Figure 2 Visual comparison of MS3 spectra of crosslinked peptides  
contrasting low-, to high-sequence coverage (90, 91). 
For a first approximation, the quality of the crosslink spectrum matches (CSMs) 
for the best scoring crosslink (between residues 510 and 609 of Mre11, discussed above) 
could be used to assess the quality of the other crosslinks identified. Since the lowest 
scoring CSM for this crosslink had an XlinkX score of 55.57, and was also confirmed 
with four complementary MS3 spectra (properly detecting both DSSO fragments for each 
peptide), these quality metrics were used as a baseline for determining which of the other 
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crosslinks to spend additional time evaluating. Two general approaches were used to 
assess the other crosslinks: spectral quality and structural analysis.  
The spectra were evaluated based upon the assigned XlinkX score, by whether an 
independent search of the same spectra using a different searching algorithm (in this case, 
Sequest HT22) and whether a visual inspection confirmed that most of the predominant 
ions in the spectrum were accounted for by the ‘expected’ peptide fragments following 
HCD fragmentation. Analysis of the crosslinks based upon known, solved protein 
structures is discussed further in the next section. 
Structural Analysis of MRN Complex 
While evidence has shown that the N-terminal region of yeast Mre11 is necessary 
for dimerization (71), in DSSO crosslinking of the human MRN complex, the N-domain 
of Mre11 did not produce any crosslinks (Figure 1). From studies of the crystal structure 
of a human Mre11 dimer, it was observed that the dimerization buried a large surface 
area of the Mre11 core (1850 Å), which might have contributed to the inability of the 
DSSO reagent to access this region (88). As depicted in Figure 3, below, the two closest 
lysine residues between the Mre11 molecules were 16.2 Å apart (K66:K105). In the mass 
spec data, both the alkene and thiol DSSO fragments were detected by the XlinkX 
algorithm at Lys-66, but the DSSO moiety at Lys-105 was hydrolyzed23, perhaps due to 
the somewhat unstructured nature of the molecule at that location, preventing 
crosslinking. 
                                                 
22
 SEQUEST® is used by Proteome Discoverer under license from the University of Washington. 
23
 Hydrolyzed DSSO modification at Lys-105 detected by the Sequest HT node. 
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Figure 3 Distance between nearest Mre11 dimer lysine residues 
was 16.2 Å. Image of PDB structure 3T1I created with  
PyMOL (88, 107). 
 
Another region in yeast Mre11, near the C-terminus, contains an acidic heptad 
repeat that was shown to be important for self-association (71, 83), and while a 
moderately homologous region exists on human Mre11 (BLASTp score of 13.9, E-value 
of 1.1, 30% identity), this putatively homologous region did not converge with a detected 
Mre11 intra-crosslink (Figure 1). The conserved Mre11 His217 residue, corresponding  
to the amino acid residue His213 in Saccharomyces cerevisiae, which, when substituted 
with tyrosine abolishes MRX complex formation, is not located near any detected 
crosslinks. 
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Figure 4 Intra-crosslink detected by mass spectrometry within Mre11 
confirmed by PDB structure 3T1I created with PyMOL (88, 99, 107). 
Three other semi-conserved residues24 within the M. jannaschii Mre11:Mre11 
interface that, when mutated (i.e. Met65Arg, Glu94Ala, Leu99Trp), abolishes Mre11 
dimerization, also did not overlap with DSSO crosslinked regions (109). However, while 
the P. furiosus residue, Leu-97 (which, when mutated, abolished the dimerization of 
Mre11) did have a homologous human residue (Ala-331) that was near the crosslinked 
Lys-360 residue (27.1 Å), the region did not correspond to an interacting region in the 
                                                 
24
 Homologous human residues adjacent to the M. jannaschii residues Met-65 and Leu-99 were conserved, 
and three residues up-to and including the M. jannaschii residue Glu-94 was conserved (human Glu-411). 
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human Mre11 PDB crystal structure 3T1I (88). However, this might be accounted for by 
the fact that the MRN complex exists in (at least) two distinct conformational states (93). 
Another observation was that one significant Mre11 intra-protein crosslink 
(matched three times with XlinkX scores between 127 and 229) was between the highly 
reactive Lys-609 residue and the FLAG-tag residue Lys-714 (see Figure 1). The 
proximity of the FLAG-tag being so close to a region of Mre11 that also associates with 
Nbs1 and Rad50 suggests that the tag may either compete or interfere with the normal 
quaternary structure of the MRN complex.  
 
 
Figure 5 Intra-crosslink detected by mass spectrometry within Rad50 
evaluated with PyMOL using homologous C. thermophilum  
PDB structure 5DAC (99, 107, 110). 
While there currently is not a solved crystallography structure of the human MRN 
complex, there are a few structures of individual proteins or of regions of interaction 
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between proteins within the complex, but not necessarily from human samples. There is a 
tetrameric crystal structure of the N-terminus (up to a.a. 400) of human Mre11 (88). The 
extent of the structure does permit evaluation of a particularly-high XlinkX scored inter-
protein link (224.25) within Mre11 detected by mass spectrometry between the Lys-360 
and Lys-384 residues. The distance measured between the α-carbons of the two lysine 
residues in PyMOL was 14.0 Å (see Figure 4, above), well within the 23.4 Å maximum 
distance constraint of the DSSO cross-linker (90). 
Two Rad50 lysine residues shown to be crosslinked by mass spectrometry were 
evaluated by measuring the distance between the analogous residues in homologous C. 
thermophilum PDB structure 5DAC (110). The measurement of 8.3 Å was especially 
impressive given the fact that the two α-carbons are separated by nearly 1,000 amino acid 
residues in the wild type protein (see Figure 5, above). 
 
Figure 6 Crosslinks at the Mre11 interacting region in Rad50  
and between Rad50 and Mre11 (99). 
The close spatial proximity of the two Rad50 lysine residues described above 
suggests that the previously annotated Mre11 interacting region (MIR) on Rad50 (111) is 
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responsible for the distal lysine inter-protein crosslinks between Rad50 and Mre11 
(Figure 6, above). 
 
Also in support of previously annotated Mre11 interacting regions on Nbs1 (81, 
85), using an XlinkX cutoff score of 100, three interlinks were detected between Mre11 
and Nbs1 (see Figure 7, below).  
 
Figure 7 Inter-crosslinks at Mre11 interacting region in Nbs1 
between Nbs1 and Mre11 (99). 
Since the human Mre11-Nbs1 complex structure has yet to be solved, the 
crosslinks between these proteins had to be evaluated using similar structures. To do so, a 
dimer from the human Mre11 tetramer PDB structure 3T1I was aligned with a 
homologous S. pombe Mre11 dimer from the Mre11-Nbs1 PDB structure 4FBW, 
enabling a visualization of the proximity of the Mre11 Lys-290 residue to the Nbs1 
peptide, which contains the Mre11 interacting region (MIR) (81, 88, 107). Despite the 
fact that homologous lysine residue does not exist in the S. pombe structure, it is 
nevertheless apparent that the human Lys-290 detected in the mass spectrometry 
crosslinking experiment aligns perfectly with the Nbs1 MIR (see Figure 8, below). The 
non-conserved S. pombe Ser-504 residue, which aligns with the human Lys-665 residue, 
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would be the last residue just upstream of the Nbs1 fragment (MIR region), but is missing 
from the 4FBW crystal structure (Figure 8) (81). 
 
 
Figure 8 Evaluation of Nbs1 MIR crosslink to Mre11 using PyMOL 
alignment of human Mre11 PDB structure 3T1I with homologous  
S. pombe Mre11-Nbs1 PDB structure 4FBW (81, 88, 107). 
While other previously-annotated interaction regions, such as the Rad50 
interacting region on the C-terminus of Nbs1 (81), were also corroborated with the mass 
spectrometry crosslinking experiment, we wanted to know whether any of the other ‘hot 
spots’25 included evolutionarily-conserved regions. While a sequence comparison 
performed on T-Coffee did not reveal any conserved regions, surprisingly, the K290 
residue on Mre11 was conserved on the five species surveyed: H. sapiens, A. fulgidus, C. 
elegans, C. cinerea and A. thaliana (see Figure 9, below). 
Lys-384 on Mre11, the second hot spot, is within a short, seven-amino acid 
α-helix located between two otherwise unstructured turns (Figure 4), likely imparting its 
ability to interact both with Rad50 and Nbs1. The third hot spot, Lys-609 of Mre11, is 
                                                 
25
 A hot spot hereby being defined as an amino acid residue found to make three or more interactions with 
one or more other proteins within the MRN complex. 
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located in the center of a region26 from a splice variant found only in isoform 1 of Mre11. 
Gene ontology annotation results from a UniProtKB peptide search27 of this region 
included the protein C-terminus binding molecular function, which suggests that this 
region might be important for protein-protein interactions.  
 
 
 
 
 
Figure 9 Mre11 ‘hot spot’ Lys-290 found to be evolutionarily conserved  
by comparing multiple species using the T-Coffee algorithm (105, 106)28. 
Accessions compared: P49959=H. sapiens, O29231=A. fulgidus, 
Q23255=C. elegans, Q9UVN9=C. cinerea and Q9XGM2=A. thaliana. 
                                                 
26
 a.a. variable splicing sequence ADTGLETSTRSRNSKTAVSASRNMSIID, annotated by NCBI 
at: https://www.ncbi.nlm.nih.gov/protein/P49959.3?report=genbank  
27
 Peptide search performed at: http://www.uniprot.org/peptidesearch/  
28
 Sequence alignment performed at: http://tcoffee.vital-it.ch/apps/tcoffee/do:regular  
H.sapiens|276–308 
A.fulgidus|228–258 
C.elegans|337–369 
C.cinerea|297–329 
A.thaliana|281–313 
K290 
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Lys-298 of Rad50, the final hot spot, is located within the P-loop superfamily 
region of the protein. In the C. thermophilum crystal structure, the analogous residue 
(Thr-1184) is located in an unstructured turn of the protein (Figure 5). As such, the 
flexibility of the region most likely accounts for the six crosslinks that were found with 
the other proteins in the complex. 
MRN Protein Complex Purity 
During analysis of the mass spectrometry data, the crosslinked peptides were 
searched against the canonical protein sequences to enable visualization of the automatic 
UniProtKB and SuperFamily annotations from the crosslink viewer website. This 
revealed a very low scoring crosslink (XlinkX score of 6.85) between Mre11 and the 
Rad50 coiled-coil zinc hook domain—a portion of the protein sequence that was deleted 
from the expressed protein. While the Rad50 peptide was clearly incorrect, its erroneous 
identification still suggested that unexpected crosslinks to contaminants might be 
occurring.  
To perform a more comprehensive search for peptide candidates, the data was 
analyzed using the much larger UniProtKB/Swiss-Prot fasta database29 (112). 
Unexpectedly, a tobacco hornworm heat shock protein was identified with 15 unique 
peptides—unprecedented for a typical contaminant besides the enzyme(s) used during 
digestion. In fact, only Mre11, Rad50 and Nbs1 were identified with more peptides, as 
would be expected.  
Since the Sf21 insect cell expression system used to clone the MRN complex 
proteins originates from Spodoptera frugiperda, the presence of a moth heat shock 
protein should not have been a surprise (85, 113). Performing the same contaminant 
                                                 
29
 There were 467k protein sequences in the 4/5/2017 release of the Swiss-Prot fasta database. 
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search, this time using a smaller fasta file from just the Ditrysia (moths, butterfly) clade, 
revealed the presence of three additional moth heat shock proteins, one of which was 
identified with 41 unique peptides (see Figure 10, below). Fortunately, while the presence 
of moth HSPs was confirmed, no crosslinks were detected between the MRN complex 
proteins and the contaminants. 
 
Figure 10 Four moth HSP contaminants in the MRN complex sample 
(marked green) in addition to the four enzymes (orange). 
FUTURE DIRECTIONS 
The hot spots identified in the crosslinking experiments should be further 
investigated by mutating specific residues, such as Lys-290 in Mre11 (Figure 9), or by 
deleting small regions, such as the seven-amino acid α-helix that encompasses Lys-384 in 
Mre11 (Figure 4), to determine if MRN interactions are abolished. 
ATM Response to Oxidative Stress 
To confirm protein aggregation in U2OS cells with ATM inhibited using 
KU-55933 (EMD Millipore, 118500), the detergent-insoluble fraction of cell lysates was 
isolated and analyzed by mass spectrometry using standard protocols previously 
described (114). As expected, the insoluble fraction contained the intermediate filaments 
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which form the cytoskeleton of aggresomes, vimentin and nestin, and were significantly 
enriched30 in the ATM inhibited cells (see Figure 11, below) (115). 
Also from the analysis of the aggresomal proteins, multiple protein clearance 
pathways were enriched, as expected. Proteins were enriched that are implicated in 
multiple protein aggregation diseases (Alzheimer's disease, Huntington's disease and 
Parkinson's disease), such as the mitochondrial ubiquinone, cytochrome and ATP 
synthase complex proteins. Other enriched pathways included the parkin-ubiquitin 
proteasomal system pathway (WP2359), Pink/Parkin Mediated Mitophagy (R-HSA-
5205685), the unfolded protein response (UPR) pathway (R-HSA-381119), E3 ubiquitin 
ligase pathway (R-HSA-8866654) and other ubiquitination and chaperone pathways… 
 
 
Figure 11 Intermediate filaments highly enriched in isolated aggresomes 
As might also have been expected, since aggresomal proteins were being 
analyzed, was that the proteasome degradation pathway (WP183) was under-represented. 
                                                 
30
 Significance of protein enrichment determined using ANOVA (with respect to background protein 
populations of the two conditions) in which the Benjamini-Hochberg adjusted p value less than 0.001. 
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What was not expected was the magnitude of the under-representation of the WP183 
pathway proteins in the ATM-inhibited sample—the FDR-adjusted p value (116) was 
5.8×e–32—especially since many other E3 ligase and molecular chaperones were present 
in the aggresome. 
In the search for a more definitive understanding of the protein-degradation 
pathology in cells undergoing oxidative stress, we endeavored to enrich proteins that 
interacted directly with ATM in cells by crosslinking the cellular proteins in vivo. To this 
end, constructs of the ATM proteins (wild-type and kinase dead)31 were transiently 
transfected into HEK-293T cells with concurrent arsenite exposure to induce oxidative 
stress, the proteins were crosslinked in cells using DSSO, and the ATM proteins were 
purified using a standard co-immunoprecipitation (co-IP) protocol (96).  
Unlike the in vitro DSSO crosslinking experiments using the purified MRN 
complex proteins, high-quality informative crosslinks were not detected between ATM 
and other proteins.32 The low level of ATM relative to the other proteins present in the 
cells were likely the primary reason for this, as even overexpressed ATM is not highly 
expressed. Also, despite using four vials of DSSO reagent per sample of harvested cells, 
this amount of reagent was still less than target reagent-to-cell count recommended by the 
protocol. Regardless, approximately 100 proteins were found exclusively in the IP of the 
cells expressing one of the ATM constructs and another 200 proteins were enriched at 
least two-fold.  
Pathway analysis of these proteins found again that the parkin-ubiquitin 
proteasomal system pathway (WP2359) was over-represented, suggesting that ATM may 
                                                 
31
 The wild type (pATMwt-Flag) and kinase deficient (pATMkd-Flag) plasmids were gifts from Michael 
Kastan. 
32
 Individual MS3 spectra confirmed ATM crosslinks, but the only protein crosslinks detected by the 
XlinkX algorithm were within and between the high abundant, non-specifically enriched proteins. 
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participate in protein clearance utilizing parkin-mediated, K63-linked polyubiquitination 
of misfolded proteins, triggering the aggregation of proteins to form perinuclear inclusion 
bodies (aggresomes) (53). 
The ATM in vivo DSSO crosslinking also did not appear to enrich many heat 
shock proteins, with the exception of HSPB1 (also called Hsp27), which was ~27% 
enriched in the cells expressing the wild type ATM construct, and ~70% enriched in the 
cells expressing the kinase-deficient ATM construct. This result is of particular interest 
because the small heat shock protein 27 has been found to be highly expressed in the 
frontal cortex of A–T patient brains, and is known for its protective role in the protein 
aggregation diseases, including ALS (54, 55). Moreover, studies have previously 
documented that ATM promotes Hsp27 phosphorylation in response to oxidative stress, 
so enrichment of this protein would be expected (58).  
 
Figure 12 Co-precipitation proteins in stress pathway with ATM 
(R-HSA-2262752, marked orange in report). 
From the group of proteins not detected in the controls, several of them shared 
with ATM the same cellular ‘stress response’ pathway (R-HSA-2262752) (see Figure 12, 
above). Being such a general pathway, it did not reveal a specific mechanism of 
interaction between the proteins. The unifying theme was the modification of histones (or 
histone variants). Otherwise, the features that tie these proteins together are that they 
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predominately reside in the nucleus, and that they bind and/or have catalytic activity for 
DNA, nucleotides or proteins.  
An overly-simplistic interaction mechanism would be for ATM to phosphorylate 
H2A.Z to affect transcriptional repression, but the histone does not contain the expected 
[ST]-Q motif near the C-terminus (as is the case with H2A.X, which is phosphorylated by 
ATM during DNA repair) (117). Instead, it contains an SQ sequence near the N-terminus, 
at the beginning of the p-family (PF00125) H2AF core domain. Moreover, the three 
detected peptides (six peptide spectrum matches) did not provide adequate protein 
coverage to discriminate between two possible protein candidates, H2A.Z and H2A.V, 
which differ in sequence by only three amino acid residues (not at the SQ location), so 
this piece of the puzzle could not be satisfactorily reconciled with this data set33.  
A more compelling mechanism would instead involve the other histone in this 
protein set—H1.4—in which the main components in the pathway might be: ROS  
ATM  p53  H1.4  repressed transcription (118-120). Moreover, p53 was enriched 
2.5:1 in the wt-ATM sample and 1.7:1 in the kd-ATM sample. Alternatively, it might 
involve the histone binding protein (RBBP7), in an interaction mechanism such as: ROS 
 ATM  ?  RBBP7  HDAC1/2  H2A  repressed transcription.  
Performing pathway analysis on the proteins that were at least two-fold enriched, 
no proteins remained in the proteasome degradation pathway (WP183). This resulted in 
an under-representation pathway with an FDR-adjusted p value score of 5×e–4 and would 
seem to reinforce the observation that ATM’s role in protein clearance during oxidative 
stress is not the direct mobilization of the proteasome. This was also in agreement with 
the results of the analysis of the previous data set from the aggresomal proteins. The other 
                                                 
33
 This data was acquired with a 40-minute acquisition—the data acquired from a 180-minute separation 
was also inconclusive. 
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significant, relevant over-represented pathways are listed in Table 1, below, and in the 
Appendix. 
 
Pathways Count Raw  
p-value 
FDR  
p-value 
Cellular responses to stress 12 4.10E-10 1.24E-07 
PRC2 methylates histones and DNA 6 3.02E-09 2.29E-07 
Cellular Senescence 8 1.50E-08 5.69E-07 
Epigenetic regulation of gene expression 7 3.58E-08 1.20E-06 
Oxidative Stress Induced Senescence 6 2.65E-07 4.88E-06 
PKMTs methylate histone lysines 5 2.74E-07 4.88E-06 
HDACs deacetylate histones 5 8.48E-07 1.17E-05 
DNA methylation 4 3.32E-06 3.86E-05 
Cell Cycle 10 4.32E-06 4.67E-05 
Nonhomologous End-Joining (NHEJ) 4 1.59E-05 1.42E-04 
G2/M DNA damage checkpoint 4 7.22E-05 4.97E-04 
Recruitment and ATM-mediated phosphorylation of repair 
and signaling proteins at DNA double strand breaks 
3 6.51E-04 3.29E-03 
DNA Double Strand Break Response 3 6.82E-04 3.33E-03 
DNA Damage/Telomere Stress Induced Senescence 3 7.14E-04 3.44E-03 
DNA Double-Strand Break Repair 4 7.71E-04 3.64E-03 
Processing of DNA double-strand break ends 3 1.57E-03 6.62E-03 
ATM Signaling Network in Development and Disease 3 6.87E-04 1.08E-02 
NF-kappa B signaling pathway 3 2.45E-03 2.74E-02 
Table 1 Over-represented pathways in enriched ATM IP samples 
 
 
Acc. Key Description Gene 
Q8IW41 MAP kinase-activated protein kinase 5 MAPKAPK5 
P68431 Histone H3.1 HIST1H3F 
P62805 histone H4 HIST1H4A 
Q71DI3 Histone H3 HIST2H3A 
P84243 histone H3.3 H3F3A 
Q16576-1 Histone-binding protein RBBP7 RBBP7 
Table 2 Oxidative Stress Induced Senescence pathway (R-HSA-1640170) 
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Figure 13 Cluster of proteins highly enriched in cells expressing ATM  
grouped by abundances. Key: Red = enriched, Green = depleted,  
White = not found, Black = quantified or parity fold change. 
Lastly, when clustering the identified proteins based upon abundances (see Figure 
13, above), and evaluating pathway over-representation, the oxidative stress induced 
senescence pathway (R-HSA-1640170) was identified with an FDR-adjusted p value 
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score of 1×e–3, reinforcing the finding that oxidative homeostasis was affected by the 
treatment with sodium arsenite (see Table 2, above).  
This filtering also elucidated an additional, highly-enriched protein with a Sequest 
score higher than ATM an abundance ratio-adjusted p value score of 4.2×e–4: Leucine-
rich PPR motif-containing protein (P42704, LRP 130). LRP 130 binds single-stranded 
DNA (ssDNA binding inferred from electronic annotation, gene ontology accession34 
GO:0003697), participates in a p53 regulatory pathway (R-HSA-5628897) and is a 
potential interacting partner of Parkin (121).  
Additional protein sequence coverage was achieved from a 3-hour acquisition, 
one particular protein stood out that had a higher Sequest score than ATM—isoform 2 of 
drebrin (Q16643-2, DBN1). A deficiency of drebrin has been linked to cognitive decline 
in Alzheimer's patients, which is of particular interest since it, too, is a protein 
aggregation disease (122). 
The unique C-terminal peptide for this isoform of the protein was identified by 
Sequest only in the kinase-dead ATM sample, with a Percolator p value score of less than 
1.0×e–4 (Percolator PEP score of 2.40×e–5, Percolator SVM score of 0.772) (123). 
Conversely, the canonical version of the protein (Q16643) contained a peptide with a 
phosphorylated serine (Ser-601) that was found only in the wild-type ATM sample 
(ptmRS site probability of 90.96%). The phosphorylated serine residue is within an SQ 
motif35,36, as is consistent with expected kinase substrates for ATM, therefore warranting 
further investigation. 
                                                 
34
 Copyright © 1999-2017 the Gene Ontology (CC-BY 4.0) 
35
 The ptmRS validated, phosphorylated residue has also previously been independently verified, and is 
annotated by UniProt. 
36
 Unexpectedly, the STQ motif was also duplicated, in succession: SQpSQ, a.a. 659 – 662. 
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FUTURE DIRECTIONS 
Another set of controls should be created to evaluate the binding partners of ATM 
when the cell is not stressed with AsO3 treatment to differentiate the role of ATM in 
oxidative homeostasis. Additionally, to reduce non-specific binding of proteins during IP 
enrichment, magnetic beads could be used for the FLAG-tag enrichment step, or the co-
IP enrichment could instead use His-tag affinity beads. Lastly, since the kinase activity of 
ATM is of central concern, alternative separation and purification techniques should be 
explored in order to enrich phosphopeptides, such as strong cation exchange/IMAC 
enrichment (124, 125). 
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CONCLUDING REMARKS 
ALTERNATIVE CROSSLINKING APPROACHES 
Crosslinking-mass spectrometry using cleavable crosslinkers is a relatively new 
protocol, and will likely require further optimization. Specifically, while the DSSO 
crosslinking reagent is cell membrane permeable, it is so at a relatively low efficiency 
(91). As such, alternative crosslinking reagents that more easily permeate the cell 
membrane, such as Disuccinimidyl Dibutyric Urea (DSBU), may prove more amenable 
to studying in vivo ATM interactions (126, 127). 
Additionally, different crosslinker lengths or other classes of crosslinking reagents 
could be used which target different amino acid residues, for instance using sulfhydryl or 
carboxylic acid, instead of amine-reactive, NHS ester chemistry (128-130). 
Lastly, protein complexes could instead be studied in wild-type cells using 
trifunctional crosslinking reagents. In this alternative approach, enrichment of protein 
complexes is performed with reactive group covalently attached to the crosslinker (such 
as biotin) instead of using tags expressed on cloned proteins (129). 
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Appendix 
OVER-REPRESENTED PATHWAYS 
The following is a selection of the pathways that were over-represented in the 
FLAG-tag IP enriched ATM sample data: 
Cell Cycle 
 
Acc. Key Description Gene 
Q13315 Serine-protein kinase ATM ATM 
P84243 histone H3.3 H3F3A 
P68431 Histone H3.1 HIST1H3F 
P62805 histone H4 HIST1H4A 
Q71DI3 Histone H3 HIST2H3A 
Q16695 histone H3.1t HIST3H3 
Q09028 Histone-binding protein RBBP4 RBBP4 
Q16576-1 Histone-binding protein RBBP7 RBBP7 
Q9Y230 RuvB-like 2 RUVBL2 
P61981 14-3-3 protein gamma YWHAG 
Table 3 Cell Cycle pathway (R-HSA-1640170) 
Cellular Senescence 
 
Acc. Key Description Gene 
Q13315 Serine-protein kinase ATM ATM 
P84243 histone H3.3 H3F3A 
P68431 Histone H3.1 HIST1H3F 
P62805 histone H4 HIST1H4A 
Q71DI3 Histone H3 HIST2H3A 
Q16695 histone H3.1t HIST3H3 
Q09028 Histone-binding protein RBBP4 RBBP4 
Q16576-1 Histone-binding protein RBBP7 RBBP7 
Table 4 Cellular Senescence pathway (R-HSA-2559583) 
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Nonhomologous End-Joining (NHEJ) 
 
Acc. Key Description Gene 
Q13315 Serine-protein kinase ATM ATM 
P62805 histone H4 HIST1H4A 
Q16695 histone H3.1t HIST3H3 
Q5UIP0 Telomere-associated protein RIF1 RIF1 
Table 5 Nonhomologous End-Joining pathway (R-HSA-5693571) 
ATM Signaling Network in Development and Disease 
 
Acc. Key Description Gene 
Q13315 Serine-protein kinase ATM ATM 
Q5UIP0 Telomere-associated protein RIF1 RIF1 
Q13263 Transcription intermediary factor 1-beta TRIM28 
Table 6 ATM Signaling Network pathway (WP3878) 
NF-kappa B signaling pathway 
 
Acc. Key Description Gene 
Q13315 Serine-protein kinase ATM ATM 
O43318 mitogen-activated protein kinase kinase kinase 7 MAP3K7 
Q15750-1 TGF-beta-activated kinase 1 and MAP3K7-
binding protein 1 
TAB1 
Table 7 NF-kappa B signaling KEGG pathway (hsa04064) 
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PROTEIN ANNOTATIONS 
The protein annotations used in the xiNET crosslink viewer displays of the MRN 
protein complex are in Table 8, below (81, 93). 
 
ProteinId AnnotName StartRes EndRes Color  
Mre11 Nuclease and capping domain 1 411 #b0e0e6 
Mre11 Rad50 interacting domain 442 477 #0000ff 
Mre11 FLAG tag 712 719 #9400d3 
Rad50 P-loop NTP hydrolases 3 182 #3cb371 
Rad50 Mre11 interacting region 183 197 #b22222 
Rad50 P-loop NTP hydrolases 198 216 #3cb371 
Rad50 DelCC linker 217 223 #ffb6c1 
Rad50 Mre11 interacting region 261 275 #b22222 
Rad50 D-loop 357 362 #ff0000 
Rad50 H-loop 386 391 #ffa500 
Rad50 HA tag 433 441 #00ff00 
Rad50 His6 tag 442 447 #1e90ff 
Nbs1 FHA domain 2 109 #4682b4 
Nbs1 BRCT I domain 114 183 #90ee90 
Nbs1 BRCT II domain 216 325 #f0e68c 
Nbs1 SPxK motif 432 435 #ffff00 
Nbs1 Mre11 interacting region 640 662 #b22222 
Nbs1 Mre11 interacting region 681 691 #b22222 
Nbs1 ATM interacting region  734 754 #ff00ff 
Table 8 MRN protein complex annotations 
MRN COMPLEX PROTEIN SEQUENCES 
The specific MRN complex protein sequences are as follows: 
Mre11 protein sequence 
>Mre11 (P49959) MRE11_HUMAN Double-strand break repair protein MRE11 
OS=Homo sapiens GN=MRE11 PE=1 SV=3 
MSTADALDDENTFKILVATDIHLGFMEKDAVRGNDTFVTLDEILRLAQENEVDFI
LLGGDLFHENKPSRKTLHTCLELLRKYCMGDRPVQFEILSDQSVNFGFSKFPWV
 49 
NYQDGNLNISIPVFSIHGNHDDPTGADALCALDILSCAGFVNHFGRSMSVEKIDIS
PVLLQKGSTKIALYGLGSIPDERLYRMFVNKKVTMLRPKEDENSWFNLFVIHQN
RSKHGSTNFIPEQFLDDFIDLVIWGHEHECKIAPTKNEQQLFYISQPGSSVVTSLSP
GEAVKKHVGLLRIKGRKMNMHKIPLHTVRQFFMEDIVLANHPDIFNPDNPKVTQ
AIQSFCLEKIEEMLENAERERLGNSHQPEKPLVRLRVDYSGGFEPFSVLRFSQKFV
DRVANPKDIIHFFRHREQKEKTGEEINFGKLITKPSEGTTLRVEDLVKQYFQTAEK
NVQLSLLTERGMGEAVQEFVDKEEKDAIEELVKYQLEKTQRFLKERHIDALEDKI
DEEVRRFRETRQKNTNEEDDEVREAMTRARALRSQSEESASAFSADDLMSIDLA
EQMANDSDDSISAATNKGRGRGRGRRGGRGQNSASRGGSQRGRADTGLETSTR
SRNSKTAVSASRNMSIIDAFKSTRQQPSRNVTTKNYSEVIEVDESDVEEDIFPTTS
KTDQRWSSTSSSKIMSQSQVSKGVDFESSEDDDDDPFMNTSSLRRNRRLGADYK
DDDDK 
Nbs1 protein sequence 
>Nbs1 (O60934) NBN_HUMAN Nibrin OS=Homo sapiens GN=NBN PE=1 SV=1 
MWKLLPAAGPAGGEPYRLLTGVEYVVGRKNCAILIENDQSISRNHAVLTANFSV
TNLSQTDEIPVLTLKDNSKYGTFVNEEKMQNGFSRTLKSGDGITFGVFGSKFRIEY
EPLVACSSCLDVSGKTALNQAILQLGGFTVNNWTEECTHLVMVSVKVTIKTICAL
ICGRPIVKPEYFTEFLKAVESKKQPPQIESFYPPLDEPSIGSKNVDLSGRQERKQIFK
GKTFIFLNAKQHKKLSSAVVFGGGEARLITEENEEEHNFFLAPGTCVVDTGITNSQ
TLIPDCQKKWIQSIMDMLQRQGLRPIPEAEIGLAVIFMTTKNYCDPQGHPSTGLKT
TTPGPSLSQGVSVDEKLMPSAPVNTTTYVADTESEQADTWDLSERPKEIKVSKM
EQKFRMLSQDAPTVKESCKTSSNNNSMVSNTLAKMRIPNYQLSPTKLPSINKSKD
RASQQQQTNSIRNYFQPSTKKRERDEENQEMSSCKSARIETSCSLLEQTQPATPSL
WKNKEQHLSENEPVDTNSDNNLFTDTDLKSIVKNSASKSHAAEKLRSNKKREM
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DDVAIEDEVLEQLFKDTKPELEIDVKVQKQEEDVNVRKRPRMDIETNDTFSDEA
VPESSKISQENEIGKKRELKEDSLWSAKEISNNDKLQDDSEMLPKKLLLTEFRSLV
IKNSTSRNPSGINDDYGQLKNFKKFKKVTYPGAGKLPHIIGGSDLIAHHARKNTE
LEEWLRQEMEVQNQHAKEESLADDLFRYNPYLKRRR 
Rad50 protein sequence 
>Rad50 (Q92878) RAD50_HUMAN DNA repair protein RAD50 OS=Homo sapiens 
GN=RAD50 PE=1 SV=1 
MSRIEKMSILGVRSFGIEDKDKQIITFFSPLTILVGPNGAGKTTIIECLKYICTGDFPP
GTKGNTFVHDPKVAQETDVRAQIRLQFRDVNGELIAVQRSMVCTQKSKKTEFKT
LEGVITRTKHGEKVSLSSKCAEIDREMISSLGVSKAVLNNVIFCHQEDSNWPLSEG
KALKQKFDEIFSATRYIKALETLRQVRQTQGQKVKEYQMELKYLKQYPPAAAG
GYREMMIVMRTTELVNKDLDIYYKTLDQAIMKFHSMKMEEINKIIRDLWRSTYR
GQDIEYIEIRSDADENVSASDKRRNYNYRVVMLKGDTALDMRGRCSAGQKVLA
SLIIRLALAETFCLNCGIIALDEPTTNLDRENIESLAHALVEIIKSRSQQRNFQLLVIT
HDEDFVELLGRSEYVEKFYRIKKNIDQCSEIVKCSVSSLGFNVHYPYDVPDYAHH
HHHH 
 
 
  
 51 
References 
 
1. Chessa L, Micheli R, & Molinaro A (2016) Focusing New Ataxia Telangiectasia 
Therapeutic Approaches. J Rare Dis Diagn Ther 2:2. 
2. Mand MR (2015) Mechanisms and consequences of ATM activation. Dissertation 
(The University of Texas at Austin). 
3. Shiloh Y & Ziv Y (2013) The ATM protein kinase: regulating the cellular 
response to genotoxic stress, and more. Nat Rev Mol Cell Biol 14(4):197-210. 
4. Watters DJ (2003) Oxidative stress in ataxia telangiectasia. Redox Rep 8(1):23-29. 
5. Ludwig LB, et al. (2013) Chromosome instability and oxidative stress markers in 
patients with ataxia telangiectasia and their parents. Biomed Res Int 2013:762048. 
6. Reichenbach J, et al. (2002) Elevated oxidative stress in patients with ataxia 
telangiectasia. Antioxid Redox Signal 4(3):465-469. 
7. Alexander A, et al. (2010) ATM signals to TSC2 in the cytoplasm to regulate 
mTORC1 in response to ROS. Proc Natl Acad Sci U S A 107(9):4153-4158. 
8. Ditch S & Paull TT (2012) The ATM protein kinase and cellular redox signaling: 
beyond the DNA damage response. Trends Biochem Sci 37(1):15-22. 
9. Guo Z, Deshpande R, & Paull TT (2010) ATM activation in the presence of 
oxidative stress. Cell Cycle 9(24):4805-4811. 
10. Uttara B, Singh AV, Zamboni P, & Mahajan RT (2009) Oxidative stress and 
neurodegenerative diseases: a review of upstream and downstream antioxidant 
therapeutic options. Curr Neuropharmacol 7(1):65-74. 
11. Lee JH, et al. (in press) ATM directs DNA damage responses and proteostasis via 
genetically separable pathways. Sci Signal. 
12. Takahashi M, et al. (2013) Stress granules inhibit apoptosis by reducing reactive 
oxygen species production. Mol Cell Biol 33(4):815-829. 
13. de Bruijn FJ (2016) Stress and environmental regulation of gene expression and 
adaptation in bacteria (John Wiley & Sons, Inc., Hoboken, New Jersey). 
14. Guo Z, Kozlov S, Lavin MF, Person MD, & Paull TT (2010) ATM Activation by 
Oxidative Stress. Science 330(6003):517-521. 
15. Shiloh Y (2003) ATM and related protein kinases: safeguarding genome integrity. 
Nat Rev Cancer 3(3):155-168. 
16. Lee JH & Paull TT (2004) Direct activation of the ATM protein kinase by the 
Mre11/Rad50/Nbs1 complex. Science 304(5667):93-96. 
17. Lee JH & Paull TT (2005) ATM activation by DNA double-strand breaks through 
the Mre11-Rad50-Nbs1 complex. Science 308(5721):551-554. 
18. Lee JH & Paull TT (2007) Activation and regulation of ATM kinase activity in 
response to DNA double-strand breaks. Oncogene 26(56):7741-7748. 
19. Sulli G, Di Micco R, & d'Adda di Fagagna F (2012) Crosstalk between chromatin 
state and DNA damage response in cellular senescence and cancer. Nat Rev 
Cancer 12(10):709-720. 
 52 
20. Zannini L, Delia D, & Buscemi G (2014) CHK2 kinase in the DNA damage 
response and beyond. J Mol Cell Biol 6(6):442-457. 
21. van Gent DC & van der Burg M (2007) Non-homologous end-joining, a sticky 
affair. Oncogene 26(56):7731-7740. 
22. Kao A, et al. (2011) Development of a novel cross-linking strategy for fast and 
accurate identification of cross-linked peptides of protein complexes. Molecular 
& cellular proteomics : MCP 10(1):M110 002212. 
23. Quick KL & Dugan LL (2001) Superoxide stress identifies neurons at risk in a 
model of Ataxia-telangiectasia. Annals of Neurology 49(5):627-635. 
24. McKinnon PJ (2004) ATM and ataxia telangiectasia. EMBO Rep 5(8):772-776. 
25. Semlitsch M, Shackelford RE, Zirkl S, Sattler W, & Malle E (2011) ATM 
protects against oxidative stress induced by oxidized low-density lipoprotein. 
DNA Repair (Amst) 10(8):848-860. 
26. Stowe DF & Camara AK (2009) Mitochondrial reactive oxygen species 
production in excitable cells: modulators of mitochondrial and cell function. 
Antioxid Redox Signal 11(6):1373-1414. 
27. Gu Z, Nakamura T, & Lipton SA (2010) Redox reactions induced by nitrosative 
stress mediate protein misfolding and mitochondrial dysfunction in 
neurodegenerative diseases. Mol Neurobiol 41(2-3):55-72. 
28. Pallardo FV, et al. (2010) Mitochondrial dysfunction in some oxidative stress-
related genetic diseases: Ataxia-Telangiectasia, Down Syndrome, Fanconi 
Anaemia and Werner Syndrome. Biogerontology 11(4):401-419. 
29. Friedman J (2011) Why is the nervous system vulnerable to oxidative stress? 
Oxidative stress and free radical damage in neurology,  (Springer), pp 19-27. 
30. Reiman A, et al. (2011) Lymphoid tumours and breast cancer in ataxia 
telangiectasia; substantial protective effect of residual ATM kinase activity 
against childhood tumours. Br J Cancer 105(4):586-591. 
31. Lavin MF, et al. (2016) Therapeutic targets and investigated treatments for 
Ataxia-Telangiectasia. Expert Opin Orphan D 4(12):1263-1276. 
32. Itoh K, et al. (1997) An Nrf2 small Maf heterodimer mediates the induction of 
phase II detoxifying enzyme genes through antioxidant response elements. 
Biochem Bioph Res Co 236(2):313-322. 
33. Malhotra D, et al. (2010) Global mapping of binding sites for Nrf2 identifies 
novel targets in cell survival response through ChIP-Seq profiling and network 
analysis. Nucleic Acids Res 38(17):5718-5734. 
34. Darvekar SR, Elvenes J, Brenne HB, Johansen T, & Sjottem E (2014) SPBP is a 
sulforaphane induced transcriptional coactivator of NRF2 regulating expression of 
the autophagy receptor p62/SQSTM1. PLoS One 9(1):e85262. 
35. Crighton D, et al. (2006) DRAM, a p53-induced modulator of autophagy, is 
critical for apoptosis. Cell 126(1):121-134. 
36. Davies MJ (2016) Protein oxidation and peroxidation. Biochemical Journal 
473(7):805-825. 
 53 
37. Voos W (2013) Chaperone-protease networks in mitochondrial protein 
homeostasis. Biochim Biophys Acta 1833(2):388-399. 
38. Lee J, Giordano S, & Zhang J (2012) Autophagy, mitochondria and oxidative 
stress: cross-talk and redox signalling. Biochem J 441(2):523-540. 
39. Cuervo AM & Wong E (2014) Chaperone-mediated autophagy: roles in disease 
and aging. Cell Res 24(1):92-104. 
40. Ciechanover A & Kwon YT (2015) Degradation of misfolded proteins in 
neurodegenerative diseases: therapeutic targets and strategies. Exp Mol Med 
47:e147. 
41. Rosser MF, Washburn E, Muchowski PJ, Patterson C, & Cyr DM (2007) 
Chaperone functions of the E3 ubiquitin ligase CHIP. J Biol Chem 
282(31):22267-22277. 
42. Lamark T & Johansen T (2012) Aggrephagy: selective disposal of protein 
aggregates by macroautophagy. Int J Cell Biol 2012:736905. 
43. Yang Y & Herrup K (2005) Loss of neuronal cell cycle control in ataxia-
telangiectasia: a unified disease mechanism. J Neurosci 25(10):2522-2529. 
44. Yang Y, Varvel NH, Lamb BT, & Herrup K (2006) Ectopic cell cycle events link 
human Alzheimer's disease and amyloid precursor protein transgenic mouse 
models. J Neurosci 26(3):775-784. 
45. Giuliano P, et al. (2003) DNA damage induced by polyglutamine-expanded 
proteins. Hum Mol Genet 12(18):2301-2309. 
46. Boder E & Sedgwick RP (1970) Ataxia-telangiectasia. (Clinical and 
immunological aspects). Psychiatr Neurol Med Psychol Beih 13-14:8-16. 
47. Savitsky K, et al. (1995) A single ataxia telangiectasia gene with a product similar 
to PI-3 kinase. Science 268(5218):1749-1753. 
48. Butch AW, Chun HH, Nahas SA, & Gatti RA (2004) Immunoassay to measure 
ataxia-telangiectasia mutated protein in cellular lysates. Clin Chem 50(12):2302-
2308. 
49. Chin LS, Olzmann JA, & Li L (2010) Parkin-mediated ubiquitin signalling in 
aggresome formation and autophagy. Biochem Soc Trans 38(Pt 1):144-149. 
50. Liu BQ, et al. (2013) BAG3-dependent noncanonical autophagy induced by 
proteasome inhibition in HepG2 cells. Autophagy 9(6):905-916. 
51. Seidel K, et al. (2012) The HSPB8-BAG3 chaperone complex is upregulated in 
astrocytes in the human brain affected by protein aggregation diseases. 
Neuropathol Appl Neurobiol 38(1):39-53. 
52. Carra S, Brunsting JF, Lambert H, Landry J, & Kampinga HH (2008) HspB8 
Participates in Protein Quality Control by a Non-chaperone-like Mechanism That 
Requires eIF2 Phosphorylation. J Biol Chem 2009(284):5523-5532. 
53. Tan JM, et al. (2008) Lysine 63-linked ubiquitination promotes the formation and 
autophagic clearance of protein inclusions associated with neurodegenerative 
diseases. Hum Mol Genet 17(3):431-439. 
54. Chen W, et al. (2009) Differential expression of small heat shock protein 27 
(Hsp27) in Ataxia telangiectasia brains. Neurochem Res 34(9):1658-1667. 
 54 
55. Muchowski PJ & Wacker JL (2005) Modulation of neurodegeneration by 
molecular chaperones. Nat Rev Neurosci 6(1):11-22. 
56. Wisniewski T & Goldman JE (1998) αB-Crystallin is Associated with 
Intermediate Filaments in Astrocytoma Cells. Neurochemical Research 
23(3):385-392. 
57. Gamerdinger M, Kaya AM, Wolfrum U, Clement AM, & Behl C (2011) BAG3 
mediates chaperone-based aggresome-targeting and selective autophagy of 
misfolded proteins. EMBO Rep 12(2):149-156. 
58. Cosentino C, Grieco D, & Costanzo V (2011) ATM activates the pentose 
phosphate pathway promoting anti-oxidant defence and DNA repair. EMBO J 
30(3):546-555. 
59. Matsuoka S, et al. (2007) ATM and ATR substrate analysis reveals extensive 
protein networks responsive to DNA damage. Science 316(5828):1160-1166. 
60. Montenarh M (2016) Protein kinase CK2 in DNA damage and repair. Transl 
Cancer Res 5(1):49-63. 
61. Duan Y, et al. (2014) HspA1A facilitates DNA repair in human bronchial 
epithelial cells exposed to Benzo[a]pyrene and interacts with casein kinase 2. Cell 
Stress Chaperones 19(2):271-279. 
62. Quanz M, et al. (2012) Heat shock protein 90alpha (Hsp90alpha) is 
phosphorylated in response to DNA damage and accumulates in repair foci. J Biol 
Chem 287(12):8803-8815. 
63. Yamamoto K, et al. (2012) Kinase-dead ATM protein causes genomic instability 
and early embryonic lethality in mice. J Cell Biol 198(3):305-313. 
64. Olive KP, et al. (2004) Mutant p53 gain of function in two mouse models of Li-
Fraumeni syndrome. Cell 119(6):847-860. 
65. Bell DW, et al. (1999) Heterozygous germ line hCHK2 mutations in Li-Fraumeni 
syndrome. Science 286(5449):2528-2531. 
66. Lee SB, et al. (2001) Destabilization of CHK2 by a missense mutation associated 
with Li-Fraumeni Syndrome. Cancer Res 61(22):8062-8067. 
67. Daniel JA, et al. (2012) Loss of ATM kinase activity leads to embryonic lethality 
in mice. J Cell Biol 198(3):295-304. 
68. Jacks T, et al. (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 
4(1):1-7. 
69. Kadyk LC & Hartwell LH (1992) Sister Chromatids Are Preferred over 
Homologs as Substrates for Recombinational Repair in Saccharomyces-
Cerevisiae. Genetics 132(2):387-402. 
70. Usui T, et al. (1998) Complex formation and functional versatility of Mre11 of 
budding yeast in recombination. Cell 95(5):705-716. 
71. Chamankhah M & Xiao W (1999) Formation of the yeast Mre11-Rad50-Xrs2 
complex is correlated with DNA repair and telomere maintenance. Nucleic Acids 
Research 27(10):2072-2079. 
72. Paull TT & Gellert M (2000) A mechanistic basis for Mre11-directed DNA 
joining at microhomologies. P Natl Acad Sci USA 97(12):6409-6414. 
 55 
73. Borde V (2007) The multiple roles of the Mre11 complex for meiotic 
recombination. Chromosome Res 15(5):551-563. 
74. Li X & Heyer WD (2008) Homologous recombination in DNA repair and DNA 
damage tolerance. Cell Res 18(1):99-113. 
75. Mao Z, Bozzella M, Seluanov A, & Gorbunova V (2008) DNA repair by 
nonhomologous end joining and homologous recombination during cell cycle in 
human cells. Cell Cycle 7(18):2902-2906. 
76. Oh J, Al-Zain A, Cannavo E, Cejka P, & Symington LS (2016) Xrs2 Dependent 
and Independent Functions of the Mre11-Rad50 Complex. Mol Cell 64(2):405-
415. 
77. Tauchi H, Matsuura S, Kobayashi J, Sakamoto S, & Komatsu K (2002) Nijmegen 
breakage syndrome gene, NBS1, and molecular links to factors for genome 
stability. Oncogene 21(58):8967-8980. 
78. Brugmans L, et al. (2009) NBS1 cooperates with homologous recombination to 
counteract chromosome breakage during replication. DNA Repair (Amst) 
8(12):1363-1370. 
79. Stewart GS, et al. (1999) The DNA double-strand break repair gene hMRE11 is 
mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99(6):577-
587. 
80. Waltes R, et al. (2009) Human RAD50 deficiency in a Nijmegen breakage 
syndrome-like disorder. Am J Hum Genet 84(5):605-616. 
81. Schiller CB, et al. (2012) Structure of Mre11-Nbs1 complex yields insights into 
ataxia-telangiectasia-like disease mutations and DNA damage signaling. Nature 
structural &amp; molecular biology 19(7):693-700. 
82. Tsubouchi H & Ogawa H (1998) A novel mre11 mutation impairs processing of 
double-strand breaks of DNA during both mitosis and meiosis. Molecular and 
Cellular Biology 18(1):260-268. 
83. Johzuka K & Ogawa H (1995) Interaction of Mre11 and Rad50: two proteins 
required for DNA repair and meiosis-specific double-strand break formation in 
Saccharomyces cerevisiae. Genetics 139(4):1521-1532. 
84. Falck J, Coates J, & Jackson SP (2005) Conserved modes of recruitment of ATM, 
ATR and DNA-PKcs to sites of DNA damage. Nature 434(7033):605-611. 
85. Deshpande RA, Lee JH, & Paull TT (2017) Rad50 ATPase activity is regulated 
by DNA ends and requires coordination of both active sites. Nucleic Acids Res 
45(9):5255-5268. 
86. Williams RS, et al. (2009) Nbs1 flexibly tethers Ctp1 and Mre11-Rad50 to 
coordinate DNA double-strand break processing and repair. Cell 139(1):87-99. 
87. You Z, Chahwan C, Bailis J, Hunter T, & Russell P (2005) ATM activation and 
its recruitment to damaged DNA require binding to the C terminus of Nbs1. Mol 
Cell Biol 25(13):5363-5379. 
88. Park YB, Chae J, Kim YC, & Cho Y (2011) Crystal structure of human Mre11: 
understanding tumorigenic mutations. Structure 19(11):1591-1602. 
 56 
89. Lee JH (2005) Characterization of the mechanisms of ATM activation by the 
MRN complex and DNA. Dissertation (ProQuest Dissertations Publishing). 
90. Liu F, Rijkers DT, Post H, & Heck AJ (2015) Proteome-wide profiling of protein 
assemblies by cross-linking mass spectrometry. Nat Methods 12(12):1179-1184. 
91. Liu F, Lossl P, Scheltema R, Viner R, & Heck AJR (2017) Optimized 
fragmentation schemes and data analysis strategies for proteome-wide cross-link 
identification. Nat Commun 8:15473. 
92. Canman CE, et al. (1998) Activation of the ATM kinase by ionizing radiation and 
phosphorylation of p53. Science 281(5383):1677-1679. 
93. Lee JH, et al. (2013) Ataxia telangiectasia-mutated (ATM) kinase activity is 
regulated by ATP-driven conformational changes in the Mre11/Rad50/Nbs1 
(MRN) complex. J Biol Chem 288(18):12840-12851. 
94. Paull TT & Gellert M (1998) The 3′ to 5′ exonuclease activity of Mre11 facilitates 
repair of DNA double-strand breaks. Molecular cell 1(7):969-979. 
95. Paull TT & Gellert M (1999) Nbs1 potentiates ATP-driven DNA unwinding and 
endonuclease cleavage by the Mre11/Rad50 complex. Genes Dev 13(10):1276-
1288. 
96. Verhagen A (2006) Using FLAG Epitope-Tagged Proteins for 
Coimmunoprecipitation of Interacting Proteins. Cold Spring Harbor Protocols 
2006(5):pdb. prot4557. 
97. Wisniewski JR, Zougman A, Nagaraj N, & Mann M (2009) Universal sample 
preparation method for proteome analysis. Nat Methods 6(5):359-362. 
98. Franz T & Li X (2015) Step-by-step preparation of proteins for mass 
spectrometric analysis. Methods in molecular biology (Clifton, N.J.) 1295:235-
247. 
99. Combe CW, Fischer L, & Rappsilber J (2015) xiNET: cross-link network maps 
with residue resolution. Molecular & cellular proteomics : MCP 14(4):1137-
1147. 
100. Consortium U (2013) Update on activities at the Universal Protein Resource 
(UniProt) in 2013. Nucleic Acids Res41: D43–D47. 
101. Gough J, Karplus K, Hughey R, & Chothia C (2001) Assignment of homology to 
genome sequences using a library of hidden Markov models that represent all 
proteins of known structure. Journal of molecular biology 313(4):903-919. 
102. Dowell RD, Jokerst RM, Day A, Eddy SR, & Stein L (2001) The distributed 
annotation system. BMC Bioinformatics 2(1):7. 
103. Johnson M, et al. (2008) NCBI BLAST: a better web interface. Nucleic Acids Res 
36(Web Server issue):W5-9. 
104. Berman HM (2000) The Protein Data Bank. Nucleic Acids Research 28(1):235-
242. 
105. Notredame C, Higgins DG, & Heringa J (2000) T-Coffee: A novel method for 
fast and accurate multiple sequence alignment. Journal of molecular biology 
302(1):205-217. 
 57 
106. Di Tommaso P, et al. (2011) T-Coffee: a web server for the multiple sequence 
alignment of protein and RNA sequences using structural information and 
homology extension. Nucleic Acids Res 39(Web Server issue):W13-17. 
107. Schrodinger, LLC (2015) The PyMOL Molecular Graphics System, Version 
2.0.1. 
108. Kall L, Canterbury JD, Weston J, Noble WS, & MacCoss MJ (2007) Semi-
supervised learning for peptide identification from shotgun proteomics datasets. 
Nat Methods 4(11):923-925. 
109. Lim HS, Kim JS, Park YB, Gwon GH, & Cho Y (2011) Crystal structure of the 
Mre11–Rad50–ATPγS complex: understanding the interplay between Mre11 and 
Rad50. Genes & development 25(10):1091-1104. 
110. Seifert FU, Lammens K, Stoehr G, Kessler B, & Hopfner KP (2016) Structural 
mechanism of ATP-dependent DNA binding and DNA end bridging by 
eukaryotic Rad50. EMBO J 35(7):759-772. 
111. Lammens K, et al. (2011) The Mre11:Rad50 structure shows an ATP-dependent 
molecular clamp in DNA double-strand break repair. Cell 145(1):54-66. 
112. Consortium U (2017) UniProt: the universal protein knowledgebase. Nucleic 
acids research 45(D1):D158-D169. 
113. Vaughn JL, Goodwin RH, Tompkins GJ, & McCawley P (1977) The 
establishment of two cell lines from the insect Spodoptera frugiperda 
(Lepidoptera; Noctuidae). In Vitro 13(4):213-217. 
114. Koplin A, et al. (2010) A dual function for chaperones SSB-RAC and the NAC 
nascent polypeptide-associated complex on ribosomes. J Cell Biol 189(1):57-68. 
115. Gregori J, Villarreal L, Sanchez A, Baselga J, & Villanueva J (2013) An effect 
size filter improves the reproducibility in spectral counting-based comparative 
proteomics. J Proteomics 95:55-65. 
116. Yekutieli D & Benjamini Y (1999) Resampling-based false discovery rate 
controlling multiple test procedures for correlated test statistics. Journal of 
Statistical Planning and Inference 82(1):171-196. 
117. Jakob B, et al. (2011) DNA double-strand breaks in heterochromatin elicit fast 
repair protein recruitment, histone H2AX phosphorylation and relocation to 
euchromatin. Nucleic Acids Res 39(15):6489-6499. 
118. Khanna KK, et al. (1998) ATM associates with and phosphorylates p53: mapping 
the region of interaction. Nat Genet 20(4):398-400. 
119. Hughes R (2016) p53 and Sp1 Associated RNAs Act as Non-coding 
Transcriptional Regulators at Homologous Loci. Masters (University of New 
South Wales). 
120. Funayama R, Saito M, Tanobe H, & Ishikawa F (2006) Loss of linker histone H1 
in cellular senescence. J Cell Biol 175(6):869-880. 
121. Davison EJ, et al. (2009) Proteomic analysis of increased Parkin expression and 
its interactants provides evidence for a role in modulation of mitochondrial 
function. Proteomics 9(18):4284-4297. 
 58 
122. Ma L, Li Y, & Wang R (2015) Drebrin and cognitive impairment. Clin Chim Acta 
451(Pt B):121-124. 
123. Spivak M, Weston J, Bottou L, Kall L, & Noble WS (2009) Improvements to the 
percolator algorithm for Peptide identification from shotgun proteomics data sets. 
J Proteome Res 8(7):3737-3745. 
124. Walker JM (2005) The proteomics protocols handbook (Springer). 
125. Villén J & Gygi SP (2008) The SCX/IMAC enrichment approach for global 
phosphorylation analysis by mass spectrometry. Nature protocols 3(10):1630-
1638. 
126. Arlt C, et al. (2016) Integrated Workflow for Structural Proteomics Studies Based 
on Cross-Linking/Mass Spectrometry with an MS/MS Cleavable Cross-Linker. 
Anal Chem 88(16):7930-7937. 
127. Muller MQ, Dreiocker F, Ihling CH, Schafer M, & Sinz A (2010) Cleavable 
cross-linker for protein structure analysis: reliable identification of cross-linking 
products by tandem MS. Anal Chem 82(16):6958-6968. 
128. Sinz A (2017) Divide and conquer: cleavable cross-linkers to study protein 
conformation and protein-protein interactions. Anal Bioanal Chem 409(1):33-44. 
129. Sinz A (2006) Chemical cross-linking and mass spectrometry to map three-
dimensional protein structures and protein-protein interactions. Mass Spectrom 
Rev 25(4):663-682. 
130. Kapoor M (1996) How to cross-link proteins. (University of Calgary, Calgary, 
Canada, 2, 1N4). 
 
 
 
 
